In the last 12 months, insiders at DAXOR CORP ($DXR) filed 46 transactions with the SEC: 26 open-market purchases totaling $149,094 and 0 sales totaling $0. Net insider sentiment: net buying.
Most Active Insiders
- Feldschuh Michael Richard (Chief Executive Officer) — 6 transactions totaling $65,113
- Michel Robert J (Chief Financial Officer) — 12 transactions totaling $35,230
- Feldschuh Michael Richard (CEO & President) — 1 transaction totaling $19,500
- Feldschuh Michael Richard (CHIEF EXECUTIVE OFFICER) — 3 transactions totaling $11,628
- Feldschuh Michael Richard (Chief Executive Office) — 1 transaction totaling $8,130
View all SEC Filings for DAXOR CORP (DXR).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Michel Robert J | Chief Financial Officer | P | Daxor Common Stock | 1000 | $9.90 | 21,050.0000 | 4,196,182 | 4.99% | 0.02% |
| March 20, 2026 | Jefferies John | Chief Medical Officer | P | Daxor Common Stock | 2285 | $0.00 | 23,557.0000 | 4,196,182 | 10.74% | 0.05% |
| March 20, 2026 | Jefferies John | Chief Medical Officer | P | Daxor Common Stock | 3656 | $0.00 | 21,272.0000 | 4,196,182 | 20.75% | 0.09% |
| Dec. 9, 2025 | Feldschuh Jonathan Adam | Chief Scientific Officer | P | Daxor Common Stock | 18000 | $0.00 | 53,908.0000 | 4,196,182 | 50.13% | 0.43% |
| Dec. 9, 2025 | Michel Robert J | Chief Financial Officer | P | Daxor Common Stock | 3000 | $0.00 | 20,050.0000 | 4,196,182 | 17.60% | 0.07% |
| Nov. 12, 2025 | Jefferies John | Chief Medical Officer | P | Daxor Common Stock | 2344 | $0.00 | 17,616.0000 | 4,196,182 | 15.35% | 0.06% |
| June 24, 2025 | Cremisi Henry D. | Director | A | Stock Options (right to buy) | 2500 | $0.00 | 2,500.0000 | 4,196,182 | 9999.99% | 0.06% |
| June 24, 2025 | Feuer Edward | Director | A | Stock Options (right to buy) | 2500 | $0.00 | 2,500.0000 | 4,196,182 | 9999.99% | 0.06% |
| June 24, 2025 | Goudie Joy S. | Director | A | Stock Options (right to buy) | 2500 | $0.00 | 2,500.0000 | 4,196,182 | 9999.99% | 0.06% |
| June 24, 2025 | DesRosiers Caleb | Director | A | Stock options (right to buy) | 2500 | $0.00 | 2,500.0000 | 4,196,182 | 9999.99% | 0.06% |
| April 4, 2025 | Feldschuh Michael Richard | Chief Executive Officer | P | Daxor Common Stock | 2063 | $7.89 | 212,694.0000 | 4,196,182 | 0.98% | 0.05% |
| March 26, 2024 | Feldschuh Michael Richard | Chief Executive Office | P | Daxor Common Stock | 1000 | $8.13 | 210,631.0000 | 4,196,182 | 0.48% | 0.02% |
| March 19, 2024 | Feldschuh Michael Richard | Chief Executive Officer | P | Daxor Common Stock | 647 | $8.15 | 209,631.0000 | 4,196,182 | 0.31% | 0.02% |
| March 10, 2024 | Feldschuh Michael Richard | Chief Executive Officer | P | Daxor Common Stock | 1492 | $7.72 | 208,984.0000 | 4,196,182 | 0.72% | 0.04% |
| March 10, 2025 | Feldschuh Michael Richard | Chief Executive Officer | P | Daxor Common Stock | 3360 | $7.68 | 210,852.0000 | 4,196,182 | 1.62% | 0.08% |
| March 10, 2025 | Michel Robert J | Chief Financial Officer | P | Daxor Common Stock | 1000 | $8.00 | 17,050.0000 | 4,196,182 | 6.23% | 0.02% |
| March 27, 2023 | Michel Robert J | Chief Financial Officer | P | Daxor Common Stock | 4750 | $0.00 | 15,050.0000 | 4,196,182 | 46.12% | 0.11% |
| Dec. 6, 2024 | Feldschuh Michael Richard | Chief Executive Officer | P | Daxor Common Stock | 45000 | $0.00 | 207,492.0000 | 4,196,182 | 27.69% | 1.07% |
| Dec. 6, 2024 | Feldschuh Jonathan Adam | Chief Scientific Officer | P | Daxor Common Stock | 32000 | $0.00 | 35,908.0000 | 4,196,182 | 818.83% | 0.76% |
| July 15, 2024 | Feuer Edward | Director | A | Stock Options (right to buy) | 2500 | $0.00 | 2,500.0000 | 4,196,182 | 9999.99% | 0.06% |
| July 15, 2024 | DesRosiers Caleb | Director | A | Stock options (right to buy) | 2500 | $0.00 | 2,500.0000 | 4,196,182 | 9999.99% | 0.06% |
| July 15, 2024 | Goudie Joy S. | Director | A | Stock Options (right to buy) | 2500 | $0.00 | 2,500.0000 | 4,196,182 | 9999.99% | 0.06% |
| July 15, 2024 | Cremisi Henry D. | Director | A | Stock Options (right to buy) | 2500 | $0.00 | 2,500.0000 | 4,196,182 | 9999.99% | 0.06% |
| March 27, 2024 | Michel Robert J | Chief Financial Officer | P | Daxor Common Stock | 750 | $8.70 | 11,300.0000 | 4,196,182 | 7.11% | 0.02% |
| March 4, 2024 | Feuer Edward | Director | P | Daxor Common Stock | 1000 | $7.21 | 1,000.0000 | 4,196,182 | 9999.99% | 0.02% |
| Dec. 6, 2023 | Michel Robert J | Chief Financial Officer | P | Daxor Common Stock | 120 | $7.75 | 10,550.0000 | 4,196,182 | 1.15% | 0.00% |
| Dec. 1, 2023 | Michel Robert J | Chief Financial Officer | P | Daxor Common Stock | 180 | $7.75 | 10,430.0000 | 4,196,182 | 1.76% | 0.00% |
| Dec. 1, 2023 | Feldschuh Michael Richard | Chief Executive Officer | P | Daxor Common Stock | 800 | $7.80 | 162,492.0000 | 4,196,182 | 0.49% | 0.02% |
| Nov. 24, 2023 | Michel Robert J | Chief Financial Officer | P | Daxor Common Stock | 500 | $7.94 | 10,250.0000 | 4,196,182 | 5.13% | 0.01% |
| Nov. 21, 2023 | Feldschuh Michael Richard | CHIEF EXECUTIVE OFFICER | A | Daxor Common Stock | 84 | $7.65 | 160,692.0000 | 4,196,182 | 0.05% | 0.00% |
| Nov. 10, 2023 | Feldschuh Michael Richard | CHIEF EXECUTIVE OFFICER | P | Daxor Common Stock | 1001 | $7.83 | 161,608.0000 | 4,196,182 | 0.62% | 0.02% |
| Nov. 9, 2023 | Feldschuh Michael Richard | CHIEF EXECUTIVE OFFICER | P | Daxor Common Stock | 401 | $7.85 | 160,607.0000 | 4,196,182 | 0.25% | 0.01% |
| Oct. 31, 2023 | Michel Robert J | Chief Financial Officer | A | Daxor Common Stock | 2000 | $0.00 | 9,750.0000 | 4,196,182 | 25.81% | 0.05% |
| Oct. 31, 2023 | Michel Robert J | Chief Financial Officer | A | Stock Options (right to buy) | 5000 | $0.00 | 5,000.0000 | 4,196,182 | 9999.99% | 0.12% |
| Oct. 13, 2023 | Michel Robert J | Chief Financial Officer | P | Daxor Common Stock | 500 | $9.02 | 7,750.0000 | 4,196,182 | 6.90% | 0.01% |
| Sept. 18, 2023 | Estate of Joseph Feldschuh | TenPercentOwner | G | Common Stock | 25000 | $0.00 | 2,549,455.0000 | 4,196,182 | 0.97% | 0.60% |
| July 11, 2023 | Feldschuh Jonathan Adam | Chief Scientific Officer | A | Stock Options (right to buy) | 25000 | $0.00 | 25,000.0000 | 4,196,182 | 9999.99% | 0.60% |
| July 11, 2023 | Feuer Edward | Director | A | Stock Options (right to buy) | 2500 | $0.00 | 2,500.0000 | 4,196,182 | 9999.99% | 0.06% |
| July 11, 2023 | Feldschuh Michael Richard | Chairman, President & CEO | A | Stock Options (right to buy) | 30000 | $0.00 | 30,000.0000 | 4,196,182 | 9999.99% | 0.71% |
| July 11, 2023 | Michel Robert J | Chief Financial Officer | A | Stock Options (right to buy) | 14000 | $0.00 | 14,000.0000 | 4,196,182 | 9999.99% | 0.33% |
| July 11, 2023 | LOMBARD JAMES A | Director | A | Stock Options (right to buy) | 2500 | $0.00 | 2,500.0000 | 4,196,182 | 9999.99% | 0.06% |
| July 11, 2023 | Cremisi Henry D. | Director | A | Stock Options (right to buy) | 2500 | $0.00 | 2,500.0000 | 4,196,182 | 9999.99% | 0.06% |
| July 11, 2023 | DesRosiers Caleb | Director | A | Stock options (right to buy) | 2500 | $0.00 | 2,500.0000 | 4,196,182 | 9999.99% | 0.06% |
| July 11, 2023 | Goudie Joy S. | Director | A | Stock Options (right to buy) | 2500 | $0.00 | 2,500.0000 | 4,196,182 | 9999.99% | 0.06% |
| May 24, 2023 | Goudie Joy S. | Director | P | Common Stock | 300 | $9.75 | 300.0000 | 4,196,182 | 9999.99% | 0.01% |
| May 24, 2023 | Feldschuh Michael Richard | CEO & President | P | Common Stock | 2000 | $9.75 | 160,206.0000 | 4,196,182 | 1.26% | 0.05% |